
Our newsletter, Risk in Perspective, periodically communicates the results of our research in a short and accessible form that emphasizes its policy relevance. Explore past issues below by following the links to the complete issues. Interested in receiving Risk in Perspective? Join our mailing list link here.
2020
Premature Deaths, Statistical Lives, and the Economic Value of Mortality Risk
Risk in Perspective, May 2020
Previous Issues
2001-2009
An Overview of “Science and Decisions: Advancing Risk Assessment”
Risk in Perspective, February 2009
Ozone and Mortality – An Update
Risk in Perspective, July 2008
Valuing “Lives Saved” vs. “Life-Years Saved”
Risk in Perspective, March 2008
Mortality Risks from Ozone Exposure
Risk in Perspective, April 2007
Air Pollution Risks in China
Risk in Perspective, January 2007
Matters of the Heart and Mind: Risk-Risk Tradeoffs
Risk in Perspective, January 2006
Regulation of Hormetic Substances
Risk in Perspective, October 2004
Weight of the Evidence Evaluation of Low-Dose Reproductive and Developmental Effect of Bisphenol A
Risk in Perspective, August 2004
Is There a Cancer Premium?
Risk in Perspective, May 2004
The Precautionary Principle in Practice: Comparing US EPA and WHO Pesticide Risk Assessments
Risk in Perspective, January 2004
The Cost of Improving Health by Reducing Emissions From Public Transit Buses
Risk in Perspective, October 2003
A Web-based Registry of Cost-Utility Analysis
Risk in Perspective, September 2003
Risk Communications: A Neglected Tool in Protecting Public Health
Risk in Perspective, June 2003
Valuing Health: Quality-Adjusted Life Years or Willingness to Pay?
Risk in Perspective, March 2003
New Technology Provides Additional Option for Women with Equivocal Pap Smear Results
Risk in Perspective, October 2002
Evaluating the Risk to Workers and the Public from Styrene Exposure
Risk in Perspective, May 2002
Evaluating the Risk of Bovine Spongiform Encephalopathy in the United States
Risk in Perspective, March 2002
The Harvard Center for Risk Analysis: Past, Present, and Future
Risk in Perspective, January 2002
Preventing Cervical Cancer in Developing Nations
Risk in Perspective, July 2001
Health Benefits of Emissions Reductions from Older Power Plants
Risk in Perspective, April 2001
The Mexico Project
Risk in Perspective, February 2001
1996-2000
Compensating Government Workers Exposed to Radiation
Risk in Perspective, September 2000
Cellular Phones and Driving: Weighing the Risks and Benefits
Risk in Perspective, July 2000
Are Pharmaceuticals Cost-Effective? Lessons for the Medicare Drug Benefit Debate
Risk in Perspective, May 2000
Kids at Risk
Risk in Perspective, April 2000
Valuing Life-Saving: Is Contingent Valuation Useful?
Risk in Perspective, March 2000
Preventing Cervical and Anal Cancer in HIV-Positive Women and Men: Using Disease-Specific Models to Develop Clinical Guidelines
Risk in Perspective, February 2000
Fueling Heavy Duty Trucks: Diesel or Natural Gas
Risk in Perspective, January 2000
1990-1995
Health Insight: A Consumer’s Guide to Taking Charge of Health Information
Risk in Perspective, October 1999
Valuing the Health Effects of Air Pollution
Risk in Perspective, July 1999
The Cost Effectiveness of New Drugs for Alzheimer’s Disease
Risk in Perspective, June 1999
The Precautionary Principle: Refine It or Replace It?
Risk in Perspective, May 1999
Toxic Pollution from Power Plants: Large Emissions, Little Risk
Risk in Perspective, April 1999
An Investor’s Look at Life-Saving Opportunities
Risk in Perspective, February 1999
The Agricultural Health Study: Strengths and Limitations
Risk in Perspective, December 1998
Gains in Life Expectancy from Medical Interventions
Risk in Perspective, November 1998
Risk-Based Environmental Advocacy
Risk in Perspective, August 1998
Patients’ Willingness to Pay for Autologous Blood Donation
Risk in Perspective, June 1998
Cancer Prevention for Individuals with Inherited Mutations
Risk in Perspective, May 1998
Ranking Risks in the Home
Risk in Perspective, April 1998
Breast Cancer Risk Factors: What Do We Know and How Well Do We Know It?
Risk in Perspective, March 1998
Whose Blood is Safer?
Risk in Perspective, February 1998
The Greening of Industry
Risk in Perspective, January 1998
Evaluating Risk Reduction Programs
Risk in Perspective, December 1997
The Sperm-Count Debate
Risk in Perspective, November 1997
Measuring Quality-Adjusted Survival for Cancer Therapies
Risk in Perspective, October 1997
Reducing Risk by Conserving Fuel and Recovering Wasted Heat
Risk in Perspective, September 1997
Risk Reform: Have You Read the Levin-Thompson Bill?
Risk in Perspective, August 1997
Airbags: Benefits and Risks
Risk in Perspective, July 1997
Coronary Heart Disease
Risk in Perspective, June 1997
Testicular Cancer: What’s Going On?
Risk in Perspective, May 1997
Forget Chemical Use, Let’s Report Risk!
Risk in Perspective, April 1997
The Importance of Modeling in the Economic Evaluation of Medical Technologies
Risk in Perspective, March 1997
Regulatory Reform: Moving Forward in the States
Risk in Perspective, February 1997
OSHA’s Program for Updating the Permissible Exposure Limits (PELs): Can Risk Assessment Help “Move the Ball Forward?”
Risk in Perspective, January 1997
Panel Issues Standards for Cost-Effectiveness Analysis
Risk in Perspective, October 1996
Breast Cancer: What are the Perceived Risk Factors?
Risk in Perspective, September 1996
Hazards in the News: Who Believes What?
Risk in Perspective, August 1996
Are Chemicals in the Environment Disrupting Hormonal Control of Growth and Development?
Risk in Perspective, April 1996
EMFs and Childhood Cancer: Are You Convinced?
Risk in Perspective, March 1996
Violence Against Women in Intimate Relationships
Risk in Perspective, February 1996
The FDA’s Oversight of Pharmacoeconomic Claims
Risk in Perspective, November 1995
Managing Risk Tradeoffs
Risk in Perspective, September 1995
Global Climate Change: Are We Over-Driving Our Headlights?
Risk in Perspective, July 1995
Cellular Telephones and Brain Cancer
Risk in Perspective, June 1995
The Human and Economic Costs of AIDS Therapies
Risk in Perspective, May 1995
Workers, EMFs, and Cancer
Risk in Perspective, April 1995
How Should Pesticides Be Regulated?
Risk in Perspective, March 1995
Complete Risk Characterization
Risk in Perspective, November 1994
EMF and Human Health – an Open Question
Risk in Perspective, October 1994
Does the Public Support Risk Analysis?
Risk in Perspective, January 1994
Lead Paint and Kids: Which Houses Should be Abated?
Risk in Perspective, November 1993
Risk Analysis and the EPA Cabinet-Elevation Bill
Risk in Perspective, September 1993
The Role of Significant Risk in OSHA Reform
Risk in Perspective, August 1993
Optimal Use of Toxic Chemicals
Risk in Perspective, May 1993
The Legacy of One in a Million
Risk in Perspective, March 1993